Dual Path Platform (DPP) Vet Tuberculosis (TB) Assay Kits

Description

{"description":" This requirement is for Dual Path Platform (DPP) Vet Tuberculosis (TB) Assay kits. These are single use immune-chromatographic tests for detection of antibodies to Mycobacterium Bovis in cervid samples and is the official test for the Federal Bovine Tuberculosis Eradication program. The test is used for the diagnosis of tuberculosis in conjunction with other diagnostic methods. quantitative analysis. \n\n RFO FAR 12.201-1 Simplified procedures will be used for awarding this contract. The anticipated award date is January 22, 2026. \n\n The intended source for this acquisition is Chembio Diagnostic Systems, Inc. \n\n The proposed contractor, Chembio Diagnostic Systems, Inc. is the only company that currently has a licensed test kit to detect antibodies in cervids for bovine tuberculosis. Chembio’s Cervid DPP is the only test that has approval to be used as part of the TB eradication program. \n\n All responsible sources may submit a response which will be considered by the agency. Please email responses to Kathy Melby at Kathleen.melby@usda.gov no later than the response date of this notice. Telephonic inquiries will not be honored. \n"} Solicitation Number: 1161063 Type: Presolicitation Base Type: Presolicitation NAICS: 325413 Classification Code: 6505 Response Deadline: 2026-01-21T03:30:00-05:00 Office Address: MINNEAPOLIS, MN Place of Performance: Iowa, 50010 POC: Kathy Melby, kathleen.melby@usda.gov {"description":" This requirement is for Dual Path Platform (DPP) Vet Tuberculosis (TB) Assay kits. These are single use immune-chromatographic tests for detection of antibodies to Mycobacterium Bovis in cervid samples and is the official test for the Federal Bovine Tuberculosis Eradication program. The test is used for the diagnosis of tuberculosis in conjunction with other diagnostic methods. quantitative analysis. \n\n RFO FAR 12.201-1 Simplified procedures will be used for awarding this contract. The anticipated award date is January 22, 2026. \n\n The intended source for this acquisition is Chembio Diagnostic Systems, Inc. \n\n The proposed contractor, Chembio Diagnostic Systems, Inc. is the only company that currently has a licensed test kit to detect antibodies in cervids for bovine tuberculosis. Chembio’s Cervid DPP is the only test that has approval to be used as part of the TB eradication program. \n\n All responsible sources may submit a response which will be considered by the agency. Please email responses to Kathy Melby at Kathleen.melby@usda.gov no later than the response date of this notice. Telephonic inquiries will not be honored. \n"}